USPSTF Prevention TaskForce vs AHA Guidelines On

The Prevention TaskForce (formerly ePSS) is an application designed and developed by the U.S. Department of Health & Human Services (HHS), Agency for Healthcare Research and Quality (AHRQ), the Nation's lead Federal agency for research on health care quality, costs, outcomes and patient safety. It was developed by AHRQ to support the independent U.S. Preventive Services Task Force (USPSTF). The USPSTF is an independent, volunteer panel of national experts in prevention and evidence-based medicine. AHRQ provides support to the USPSTF. The Prevention TaskForce application was developed to assist primary care clinicians identify the screening, counseling, and preventive medication services that are appropriate for their patients. The Prevention TaskForce information is based on the current recommendations of the U.S. Preventive Services Task Force (USPSTF) and can be searched by specific patient characteristics, such as age, sex, and selected behavioral risk factors. When using this tool please read the specific recommendation to determine if the preventive service is appropriate for your patient. This tool is not meant to replace clinical judgment and individualized patient care. *Application downloads and data updates require internet connectivity

Access guidelines on your mobile device anytime, anywhere! Download the American Heart Association mobile app today and enjoy the benefits of staying up-to-date no matter where you are. Effective integration of complex clinical treatment guidelines, tagged and mapped for effective search with cross-linking, resources and more. Additional guidelines will be added soon! Disclaimer: The clinical guidelines, care pathways, and other clinical guidance and recommendations presented in the AHA on-the-go Guidelines App were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The results and recommendations provided in this application do not replace clinical judgment of the care provider. Therapeutic options should be individualized and determined after discussion between the patient and their care provider.